AMOREPACIFIC CORP. - Company Intelligence Brief

1. Business Overview

[TRANSLATION NOTE] AMOREPACIFIC CORP. (KRX: 090430) is South Korea's leading cosmetics and beauty conglomerate. Based on available DART filing data, the company operates on a consolidated basis (연결재무제표) with substantial international operations. The company's fiscal year 2024 (제 19기) represents its 19th business year since restructuring. With a market capitalization of approximately KRW 7.6 trillion, AMOREPACIFIC is among Korea's largest beauty companies, encompassing premium cosmetics brands and skincare products distributed domestically and internationally.

2. Financial Trend

AMOREPACIFIC shows a cautious recovery trajectory. Revenue increased 5.7% year-over-year to KRW 3,885 billion in 2024 from KRW 3,674 billion in 2023, though still below the 2022 peak of KRW 4,135 billion. Operating profit more than doubled to KRW 220 billion (2024) from KRW 108 billion (2023), representing an operating margin improvement from 2.9% to 5.7%. Net income surged 246% to KRW 602 billion in 2024 versus KRW 174 billion in 2023.

The balance sheet reveals strategic capital deployment. Total assets increased 15.2% to KRW 6,784 billion, driven primarily by a 28.3% surge in non-current assets to KRW 5,049 billion, while current assets declined 11.1% to KRW 1,735 billion. Total liabilities rose 43.8% to KRW 1,457 billion, with both current liabilities (KRW 1,096 billion, +34.7%) and non-current liabilities (KRW 362 billion, +80.4%) increasing substantially. Despite this, the debt-to-equity ratio remains conservative at 27.4%, with retained earnings growing to KRW 4,601 billion. The company maintains a solid equity base of KRW 5,326 billion.

3. Ownership Structure

Specific ownership structure data is not included in the provided DART filing excerpts. The consistent stated capital of KRW 34.5 billion across all three years (2022-2024) indicates no new equity issuance. Foreign ownership percentage and controlling shareholder information would require additional disclosure documents not present in this dataset.

4. Key Risks

China Market Dependency: The sharp revenue decline from 2022 (KRW 4,135 billion) through 2023 (KRW 3,674 billion) suggests significant exposure to Chinese consumer sentiment shifts and geopolitical tensions affecting Korean beauty brands. The incomplete recovery by 2024 indicates ongoing structural challenges.

Aggressive Asset Expansion Amid Debt Growth: The 28% jump in non-current assets concurrent with 81% growth in non-current liabilities and 35% increase in current liabilities signals major capital commitments—potentially M&A, facility expansion, or brand acquisitions—whose returns remain unproven given operating margins still in low-single digits.

5. Investment Consideration

AMOREPACIFIC presents a turnaround story with dramatically improved profitability in 2024, but investors must weigh operational recovery against elevated balance sheet risk from recent aggressive capital deployment and persistent revenue challenges below historical peaks.